Overview
The purpose of this research is to better understand how benign breast diseases might lead to breast cancer, focusing on genetic factors and including a diverse range of participants to improve future diagnosis and treatment.
Eligibility
Inclusion Criteria:
- Female patients, ages 18 to 100 years
- Had a benign breast biopsy at Mayo Clinic between 2002-2022
Exclusion Criteria:
- All male patients
- Prior or concomitant diagnosis of BC
- Diagnosis of BC within six months of benign breast disease
- Denial of research authorization
- Concurrent or post-biopsy bilateral prophylactic mastectomy